Title : Efficacy, safety and pharmacokinetics of palonosetron in patients receiving highly emetogenic cisplatin-based chemotherapy: a dose-ranging clinical study.

Pub. Date : 2004 Feb

PMID : 14760130






2 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Palonosetron, a potent and highly selective 5-HT3 antagonist with a strong affinity for 5-HT3 and a prolonged plasma elimination half-life, may provide a longer duration of action than other approved agents. Palonosetron 5-hydroxytryptamine receptor 3A Homo sapiens
2 Palonosetron, a potent and highly selective 5-HT3 antagonist with a strong affinity for 5-HT3 and a prolonged plasma elimination half-life, may provide a longer duration of action than other approved agents. Palonosetron 5-hydroxytryptamine receptor 3A Homo sapiens